Improving cervical cancer control policies using mathematical modeling

Comparative Modeling to Inform Cervical Cancer Control Policies

NIH-funded research Harvard School of Public Health · NIH-10915457

This study is looking at how to improve ways to prevent cervical cancer by using smart math models to combine information about HPV screening and vaccines, helping decision-makers find the best and fairest strategies for everyone.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionHarvard School of Public Health NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-10915457 on NIH RePORTER

What this research studies

This research focuses on enhancing cervical cancer control strategies by utilizing advanced mathematical modeling techniques. It aims to synthesize existing data on HPV-related technologies, such as screening and vaccination, to inform decision-makers about effective and equitable approaches to cervical cancer prevention. By simulating various scenarios, the project seeks to predict long-term outcomes and optimize resource allocation for cervical cancer programs. The collaboration involves multiple modeling groups from the US, Australia, and the Netherlands, ensuring a comprehensive analysis of the issue.

Who could benefit from this research

Good fit: Ideal candidates for this research include women at risk for cervical cancer, particularly those who may benefit from improved screening and vaccination strategies.

Not a fit: Patients who have already been diagnosed with advanced cervical cancer may not benefit directly from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective cervical cancer prevention strategies, ultimately reducing the incidence and mortality rates associated with the disease.

How similar studies have performed: Previous research using mathematical modeling for cancer control has shown promise, indicating that this approach could yield valuable insights for cervical cancer prevention.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusCancer BurdenCancer ControlCancer Control Science
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.